يعرض 1 - 20 نتائج من 101 نتيجة بحث عن '"Miller, R.S."', وقت الاستعلام: 0.45s تنقيح النتائج
  1. 1
    Academic Journal

    المساهمون: Department of Surgery, University of Arizona

    المصدر: Scientific Reports

    Relation: Donohue, J.K., Gruen, D.S., Iyanna, N. et al. Mechanism matters: mortality and endothelial cell damage marker differences between blunt and penetrating traumatic injuries across three prehospital clinical trials. Sci Rep 14, 2747 (2024). https://doi.org/10.1038/s41598-024-53398-1; http://hdl.handle.net/10150/673177; Scientific Reports

  2. 2
    Academic Journal

    المساهمون: Department of Physics and Astronomy, The University of Arizona

    المصدر: Astrophysical Journal

    Relation: Christopher L. Fryer et al 2023 ApJ 956 19; http://hdl.handle.net/10150/671399; Astrophysical Journal

  3. 3
    Academic Journal
  4. 4
  5. 5
    Academic Journal
  6. 6
    Academic Journal
  7. 7
    Academic Journal
  8. 8
    Academic Journal
  9. 9
  10. 10
    Academic Journal
  11. 11
    Academic Journal

    المصدر: Journal of Clinical Oncology, 37(9)

  12. 12
    Academic Journal
  13. 13
    Academic Journal
  14. 14
  15. 15
    Academic Journal

    وصف الملف: application/pdf

    Relation: Kim, C.; Miller, R.S.; Braffett, B.H.; Pan, Y.; Arends, V.L.; Saenger, A.K.; Barnie, A.; Sarma, A.V. (2018). "Ovarian markers and irregular menses among women with type 1 diabetes in the Epidemiology of Diabetes Interventions and Complications study." Clinical Endocrinology (3): 453-459.; https://hdl.handle.net/2027.42/142421; Clinical Endocrinology; Codner E, Escobar‐Morreale H. Clinical review: hyperandrogenism and polycystic ovary syndrome in women with type 1 diabetes mellitus. J Clin Endocrinol Metab. 2007; 92: 1209 ‐ 1216.; American College of Obstetricians and Gynecologists Committee on Gynecologic Practice and Practice Committee. Female age‐related fertility decline. Committee Opinion No. 589. 2014;101 3.; Purnell J, Hokanson J, Marcovina S, Steffes M, Cleary P, Brunzell J. Effect of excessive weight gain with intensive therapy of type 1 diabetes on lipid levels and blood pressure: Results from the Diabetes Control and Complications Trial. JAMA. 1998; 280: 140 ‐ 146.; Tatone C, Carbone M, Campanella G, et al. Female reproductive dysfunction during ageing: role of methylglyoxal in the formation of advanced glycation endproducts in ovaries of reproductively‐aged mice. J Biol Regul Homeost Agents. 2010; 24: 63 ‐ 72.; Nandi A, Poretsky L. Diabetes and the female reproductive system. Endocrinol Metab Clin North Am. 2013; 42: 915 ‐ 946.; Escobar‐Morreale H, Roldan‐Martin M. Type 1 diabetes and polycystic ovary syndrome: systematic review and meta‐analysis. Diabetes Care. 2016; 39: 639 ‐ 648.; Epidemiology of Diabetes Interventions and Complications (EDIC). Design, implementation, and preliminary results of a long‐term follow‐up of the Diabetes Control and Complications Trial cohort. Diabetes Care. 1999; 22: 99 ‐ 111.; Diabetes Control and Complications Trial (DCCT): results of feasibility study. The DCCT Research Group. Diabetes Care. 1987; 10: 1 ‐ 19.; Retinopathy and nephropathy in patients with type 1 diabetes four years after a trial of intensive therapy. The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group. N Engl J Med. 2000; 342: 381 ‐ 389.; Kim C, Cleary P, Cowie C, et al. Effect of glycemic treatment and microvascular complications on menopause in women with type 1 diabetes in the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) cohort. Diabetes Care. 2014; 37: 701 ‐ 708.; Kim C, Pan H, Braffett B, et al. AMH in women with and without type 1 diabetes in the EDIC and MBHMS cohorts. Fertil Steril. 2016; 106: 1446 ‐ 1452.; Azziz R, Carmina E, Dewailly D, et al. The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report. Fertil Steril. 2009; 91: 456.; Lebkowska A, Adamska A, Karcewska‐Kupcsewska M, et al. Serum anti‐Mullerian hormone concentrations in women with polycystic ovary syndrome and type 1 diabetes mellitus. Metabolism. 2016; 65: 804 ‐ 811.; Dewailly D, Pigney P, Soudan B, et al. Reconciling the definitions of polycystic ovary syndrome: the ovarian follicle number and serum anti‐Mullerian hormone concentrations aggregate with the markers of hyperandrogenism. J Clin Endocrinol Metab. 2010; 95: 4399 ‐ 4405.; Codner E, Iniguez G, Villarroel C, et al. Hormonal profile in women with polycystic ovarian syndrome with or without type 1 diabetes mellitus. J Clin Endocrinol Metab. 2007; 92: 4742 ‐ 4746.; Carmina E, Campagna A, Lobo R. A 20‐year follow‐up of young women with polycystic ovary syndrome. Obstet Gynecol. 2012; 119: 263 ‐ 269.; Brown Z, Louwers Y, Fong S, et al. The phenotype of polycystic ovary syndrome ameliorates with aging. Fertil Steril. 2011; 96: 1259 ‐ 1265.; Strotmeyer E, Steenkiste A, Foley T Jr, Berga S, Dorman J. Menstrual cycle differences between women with type 1 diabetes and women without diabetes. Diabetes Care. 2003; 26: 1016 ‐ 1021.; Adcock C, Perry L, Lindsell D, Taylor A, Jones J, Dunger D. Menstrual irregularities are more common in adolescents with type 1 diabetes: association with poor glycaemic control and weight gain. Diabet Med. 1994; 11: 465 ‐ 470.; Arrais R, Dib S. The hypothalamus‐pituitary‐ovary axis and type 1 diabetes mellitus: a mini‐review. Hum Reprod. 2006; 21: 327 ‐ 337.; Rosner W, Vesper H. Toward excellence in testosterone testing: a consensus statement. J Clin Endocrinol Metab. 2010; 95: 4542 ‐ 4548.; Soto N, Iniguez G, Lopez P, et al. Anti‐Mullerian hormone and inhibin B levels as markers of premature ovarian aging and transition to menopause in type 1 diabetes mellitus. Hum Reprod. 2009; 24: 2838 ‐ 2844.; Soto N, Pruzzo R, Eyzaguirre F, et al. Bone mass and sex steroids in postmenarcheal adolescents and adult women with type 1 diabetes mellitus. J Diabetes Complications. 2011; 25: 19 ‐ 24.; Salonia A, Lanzi R, Scavini M, et al. Sexual function and endocrine profile in fertile women with type 1 diabetes. Diabetes Care. 2006; 29: 312 ‐ 316.; Escobar‐Morreale H, Roldan B, Barrio R, et al. High prevalence of the polycystic ovary syndrome and hirsutism in women with type 1 diabetes mellitus. J Clin Endocrinol Metab. 2000; 85: 4182 ‐ 4187.; Wiebe J, Santana A, Medina‐Rodriguez N, et al. Fertility is reduced in women and in men with type 1 diabetes: results from the Type 1 Diabetges GEnetics Consortium (T1DGC). Diabetologia. 2014; 57: 2501 ‐ 2504.; Sjoberg L, Pitkaniemi J, Haapala L, Kaaja R, Tuomilehto J. Fertility in people with childhood‐onset type 1 diabetes. Diabetologia. 2013; 56: 78 ‐ 81.; Whitworth K, Baird D, Stene L, Skjaerven R, Longnecker M. Fecundability among women with type 1 and type 2 diabetes in the Norwegian Mother and Child Cohort Study. Diabetologia. 2011; 54: 516 ‐ 522.; Jonasson J, Brismar K, Sparen P, et al. Fertility in women with type 1 diabetes: a population‐based cohort study in Sweden. Diabetes Care. 2007; 30: 2271 ‐ 2276.; Codner E, Eyzaguirre F, Iniguez G, et al. Ovulation rate in adolescents with type 1 diabetes mellitus. Fertil Steril. 2011; 95: 197 ‐ 202.; Buschur E, Sarma A, Pietropaolo M, et al. Self‐reported autoimmune disease by sex in the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study. Diabetes Care. 2014; 37: E28 ‐ E29.; Dewailly D, Andersen C, Balen A, et al. The physiology and clinical utility of anti‐Mullerian hormone in women. Hum Reprod. 2013; 20: 370 ‐ 385.; Meyer K, Deutscher J, Anil M, Berthold A, Bartsch M, Kiess W. Serum androgen levels in adolescents with type 1 diabetes: relationship to pubertal stage and metabolic control. J Endocrinol Invest. 2000; 23: 362 ‐ 368.

  16. 16
    Academic Journal
  17. 17
    Academic Journal
  18. 18
    Academic Journal
  19. 19
    Conference
  20. 20
    Conference